Variant report

Variant	nsv963525
Chromosome Location	chr3:86920310-86948539
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 868 )
Associated
traits (count: 75 )

Variant overlapped rSNPs/rCNVs (count:868 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs549494844	chr3:86920324-86920325	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs558363537	chr3:86920363-86920364	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs567691592	chr3:86920385-86920386	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs568379431	chr3:86920452-86920453	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs534694396	chr3:86920483-86920484	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs141406964	chr3:86920515-86920516	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs565858448	chr3:86920569-86920570	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs539674507	chr3:86920579-86920580	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs557542885	chr3:86920604-86920605	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs146590207	chr3:86920644-86920645	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs75655478	chr3:86920672-86920673	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs555025546	chr3:86920717-86920718	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs543846817	chr3:86920719-86920720	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs573643566	chr3:86920799-86920800	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs189009340	chr3:86920821-86920822	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs373336393	chr3:86920838-86920839	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs191165686	chr3:86920860-86920861	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs533464915	chr3:86920870-86920871	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs62257279	chr3:86920871-86920872	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs563917291	chr3:86920906-86920907	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs531103955	chr3:86920928-86920929	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs574362350	chr3:86920929-86920930	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs543261344	chr3:86920961-86920962	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs559948759	chr3:86920980-86920981	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs182951870	chr3:86920989-86920990	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs528557541	chr3:86921011-86921012	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs187589332	chr3:86921030-86921031	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs528602820	chr3:86921031-86921032	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs191661117	chr3:86921042-86921043	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs553052688	chr3:86921044-86921045	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs138734477	chr3:86921067-86921068	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs539394570	chr3:86921082-86921083	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs183305996	chr3:86921100-86921101	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs557628872	chr3:86921169-86921170	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs188162855	chr3:86921173-86921174	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs565224853	chr3:86921187-86921188	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs192692073	chr3:86921201-86921202	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs371262454	chr3:86921210-86921211	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs573654802	chr3:86921217-86921218	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs149341821	chr3:86921253-86921254	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs552733326	chr3:86921266-86921267	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs550679485	chr3:86921327-86921328	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs377059144	chr3:86921361-86921362	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs545744240	chr3:86921363-86921364	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs184493491	chr3:86921368-86921369	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs189245094	chr3:86921392-86921393	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs143824573	chr3:86921425-86921426	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs561486867	chr3:86921431-86921432	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs555188910	chr3:86921452-86921453	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs192600612	chr3:86921453-86921454	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:75)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Melanoma	18172304	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Acute myeloid leukemia	20729466	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Hirschsprung''s Disease	21712996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	21965145	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Metanephric adenoma	20802469	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Wilms tumour	21544195	CNVD
Colorectal cancer	16272173	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Soft tissue tumor	16732325	CNVD
small cell lung cancer	20016488	CNVD
Neurodevelopmental disorder	22521361	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Mental retardation	17124404	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Myelofibrosis	22110671	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
craniofacial dysmorphism	21918468	CNVD
Cancer	20164920	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:69 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:86919800-86938600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr3:86922800-86927400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr3:86925200-86926000	Enhancers	H1 Cell Line	embryonic stem cell
4	chr3:86925600-86925800	Enhancers	iPS-18 Cell Line	embryonic stem cell
5	chr3:86925600-86927800	Enhancers	iPS-20b Cell Line	embryonic stem cell
6	chr3:86925800-86926000	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr3:86925800-86926400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
8	chr3:86925800-86927000	Enhancers	HUES48 Cell Line	embryonic stem cell
9	chr3:86925800-86927200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
10	chr3:86926000-86927000	Weak transcription	HUES6 Cell Line	embryonic stem cell
11	chr3:86926000-86927400	Weak transcription	H1 Cell Line	embryonic stem cell
12	chr3:86926200-86927800	Enhancers	iPS-15b Cell Line	embryonic stem cell
13	chr3:86926600-86928400	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr3:86927000-86927400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
15	chr3:86927000-86927800	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr3:86927200-86928400	Enhancers	iPS-18 Cell Line	embryonic stem cell
17	chr3:86927400-86927800	Enhancers	H1 Cell Line	embryonic stem cell
18	chr3:86927400-86927800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr3:86927400-86927800	Enhancers	HUES48 Cell Line	embryonic stem cell
20	chr3:86927600-86927800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
21	chr3:86927800-86929200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
22	chr3:86927800-86939000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
23	chr3:86928400-86937200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
24	chr3:86929200-86929800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr3:86932000-86932600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr3:86932600-86933000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr3:86932800-86933000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr3:86933000-86933200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr3:86937200-86937800	Enhancers	iPS-18 Cell Line	embryonic stem cell
30	chr3:86937400-86937600	Enhancers	H1 Cell Line	embryonic stem cell
31	chr3:86937400-86937600	Enhancers	HUES48 Cell Line	embryonic stem cell
32	chr3:86937600-86939000	Weak transcription	H1 Cell Line	embryonic stem cell
33	chr3:86937600-86939000	Weak transcription	HUES48 Cell Line	embryonic stem cell
34	chr3:86937800-86938200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
35	chr3:86938200-86940000	Enhancers	iPS-18 Cell Line	embryonic stem cell
36	chr3:86938600-86941000	Enhancers	ES-I3 Cell Line	embryonic stem cell
37	chr3:86938600-86942000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
38	chr3:86939000-86939400	Enhancers	HUES48 Cell Line	embryonic stem cell
39	chr3:86939000-86939800	Enhancers	iPS-20b Cell Line	embryonic stem cell
40	chr3:86939000-86940800	Enhancers	H1 Cell Line	embryonic stem cell
41	chr3:86939000-86941400	Enhancers	iPS-15b Cell Line	embryonic stem cell
42	chr3:86939000-86941800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr3:86939000-86941800	Enhancers	HUES64 Cell Line	embryonic stem cell
44	chr3:86939200-86939400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
45	chr3:86939200-86940800	Enhancers	HUES6 Cell Line	embryonic stem cell
46	chr3:86939400-86940600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
47	chr3:86939400-86941600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
48	chr3:86939800-86940400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
49	chr3:86939800-86940800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
50	chr3:86939800-86940800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links